Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03370536 · ClinicalTrials.gov registry record · NA
ECGi Ibutilide: Effect of Ibutilide on AF Source Location and Organization
A NA study, sponsored by Vivek Reddy.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT03370536 is a NA study that was terminated before completion, run by Vivek Reddy. The registered enrollment target is 1 participants.
The verdict
NCT03370536, a NA study, was terminated before completion, sponsored by Vivek Reddy.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
This is a prospective, multi-center, non-randomized, un-blinded, observational trial.
Interventions
- DRUG Ibutilide
- DEVICE CardioInsight ECGI Mapping System
- PROCEDURE AF ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2018-07-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03370536
The ClinicalTrials.gov registry entry for NCT03370536 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vivek Reddy, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ibutilide is the first listed.
NCT03370536 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03370536 about?
NCT03370536 is a clinical study titled "ECGi Ibutilide: Effect of Ibutilide on AF Source Location and Organization". This is a prospective, multi-center, non-randomized, un-blinded, observational trial.
What is the current status of trial NCT03370536?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2017-11-01. Estimated completion is 2018-07-18.
What interventions are being tested in trial NCT03370536?
The interventions under investigation include: Ibutilide (DRUG), CardioInsight ECGI Mapping System (DEVICE), AF ablation (PROCEDURE).
Who is sponsoring clinical trial NCT03370536?
This trial is sponsored by Vivek Reddy, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.